c) up to $1 million deferred consideration to be paid after 31 March 2022 based on the total contract value of perpetual licence sales of products acquired determined as at 31 March 2022.
The deferred consideration in (c) above will be paid through the issue of shares at a price equal to the higher of: a) the share price which is a 15% discount to the closing price of the Purchaser’s shares on the date of execution of the agreement; and b) the 30-day VWAP over the 30 days in which trades occur in the Purchaser’s shares immediately prior to 31 March 2022. The maximum number of shares that may be issued for the deferred consideration is therefore 3,095,975.
CPT Price at posting:
3.3¢ Sentiment: Hold Disclosure: Not Held
